United States Of America to India: Protein Import Trade Route

The United States Of America to India Protein corridor is one of India's established pharmaceutical import routes from United States Of America, with 16 shipments documented worth a combined $74.5K USD. The route is dominated by XXEHRXXGERXXNGEXXEIMXXHARXXCEUXXCALXXINC, which alone accounts for roughly 41% of all import value, reflecting the consolidated nature of United States Of America's protein export sector.

Across 11 active United States Of America suppliers, the average shipment value stands at $4.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with protein's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 30.8%, placing it at rank #15 among India's top protein import origins globally.

On the Indian buyer side, key Indian importers include SYNGENE INTERNATIONAL LIMITED, SERUM INSTITUTE OF INDIA PRIVATE LIMITED. SYNGENE INTERNATIONAL LIMITED is the single largest Indian importer with 14 shipments valued at $58.1K USD.

India's protein imports from United States Of America are driven primarily by a handful of large-scale United States Of America manufacturers. XXEHRXXGERXXNGEXXEIMXXHARXXCEUXXCALXXINC with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — Indian buyers benefit from United States Of America supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — XXEHRXXGERXXNGEXXEIMXXHARXXCEUXXCALXXINC, XXGENXXINC, XXVAVXX IXX — together account for 84% of total trade value on this route. The average shipment value of $4.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as foc value for customs purpose highly purified recombinant protein 25ugug .3mg and anti-sars-cov-2 spike glycoprotein antibody coronavirus lot 1050325-3 (qty: 3 mg)(foc cons. no. 404/ncg/2023-24), suggesting that Indian buyers tend to consolidate orders across related product lines from the same United States Of America supplier.

On the buying side, SYNGENE INTERNATIONAL LIMITED is the largest importer with 14 shipments worth $58.1K USD — representing 78% of all protein imports from United States Of America on this route.